Covaxin submits phase-3 trial data for WHO approval

June 17, 2021 09:30

Moving towards global approval, India's indigenous COVID vaccine Covaxin has submitted its phase-3 clinical trial data to WHO on Wednesday, for its authorisation.

Sources state that Covaxin's approval application will be taken up for consideration by WHO on June 23. As per WHO's website, six vaccines -- Pfizer, AstraZeneca, Sinopharm, Moderna, Sinovac and Johnson & Johnson have been approved for global usage.

India's other vaccine - Covishield has received Emergency approval by WHO.

Moreover, BBL informed that Covaxin will even undergo phase-4 trials to check the real-world effectiveness of the vaccines to meet every rigorous scientific standard for safety, effectiveness, and manufacturing quality needed to support emergency use authorisation.

« Back to LIVE

TOP STORIES

Nepal's Rs 100 note to feature new map with disputed Indian territories

India maintains Lipulekh, Kalapani and Limpiyadhura belong to it.

Cong social media team coordinator held for Amit Shah fake video

Arun Beereddy (37), a native of Telangana's Hyderabad, was arrested from Delhi. He handles the 'Spirit of Congress' account on X, the official said.

IPL 2024: What is going wrong for MI? Here's what Hardik said...

Mumbai Indians skipper Hardik Pandya seemed to be at a loss for words to explain the reasons for his team's disastrous showing in IPL 2024 so far.

IPL PIX: Clinical KKR outclass MI; inch closer to play-offs!

Kolkata Knight Riders outclassed Mumbai Indians by 24 runs in the IPL 2024 match on Friday.

Canadian police arrest 3 suspects in Nijjar murder case: Media report

Three people have been arrested and charged in the killing of Sikh activist Nijjar, CTV News quoted a senior government source as saying.